Regenerative Medicine and Stem Cells Technologies

Grail has taken a few more steps forward in its quest to develop a diagnostic test capable not only of spotting cancer in its earliest stages, but also identifying its location within the body using markers taken from the bloodstream.

Artificial neurons on silicon chips that behave just like the real thing have been invented by scientists – a first-of-its-kind achievement with enormous scope for medical devices to cure chronic diseases, such as heart failure, Alzheimer’s, and other diseases of neuronal degeneration.

Researchers at the Broad Institute of MIT and Harvard (both MA, USA) have designed a Cas13–CRISPR construct that can act as a diagnostic and antiviral. The ‘CARVER’ system, detailed in Molecular Cell, offers promise for tackling emerging and drug-resistant RNA viruses.

Bone fracture healing can be augmented with the application of pulsed electromagnetic fields (PEMFs), but a consensus regarding idealized conditions is lacking. A new study characterizes the in vitro effects of these PEMFs on the crucial osteoblast precursor cells and seeks to determine the optimal conditions that will promote bone regeneration.

In adult skeletal muscle, loss of myofiber integrity caused by mechanical injuries or diseases are repaired by resident muscle stem cells, called satellite cells, which promptly exit from quiescence after disruption of muscle architecture to expand, differentiate and drive tissue regeneration.

Caltech researchers have helped to design a new generation of heart valves that are longer-lasting, cost less to manufacture, and are more biocompatible than options that are currently available to patients. As part of an FDA trial, one of the new valves was implanted into a human for the first time in late July.

Drug-eluting contact lenses, which gradually release drugs into the eye, offer a promising alternative to daily eye drops, which can be unpleasant and hard for patients to properly administer.

The advisor to the vice president for science and technology affairs stated: as the head of a business delegation encompassing the managers of Iranian knowledge-based companies, Sorena Sattari, the vice president for science and technology affairs, will travel to Turkey.

The third “menstrual blood stem cell bank” of the world is established in Iran to accelerate the pace of treatment of women"s infertility, early menopause treatment, fertility preservation, reproductive medicine and some other diseases.

The number of knowledge-based companies in the field of stem cells and regenerative medicine increased to 100 in 2019. This number of companies have generated about one thousand jobs.